AXLA实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (30 Dec 2023 @ 04:59):

Stats
今日成交量	6 782.00
平均成交量	54 521.00
市值	1.18M
EPS	$0 ( 2024-03-28 )
下一个收益日期	( $0 ) 2024-05-02
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0220
ATR14	$0.625 (155.90%)

Insider Trading

Date	Person	Action	Amount	type
2023-03-01	Koziel Margaret	Sell	679	Common Stock
2023-02-17	Koziel Margaret	Buy	70 000	Stock Option (Right to Buy)
2023-02-17	Hinshaw William	Buy	275 000	Stock Option (Right to Buy)
2023-02-17	Fehlner Paul	Buy	70 000	Stock Option (Right to Buy)
2023-02-10	Fehlner Paul	Buy	5 221	Common Stock

INSIDER POWER
99.86
Last 92 transactions
Buy: 44 458 855 \| Sell: 477 523

音量相关性

長: 0.47 (neutral)

短: 0.41 (neutral)

Signal:(20.847) Neutral

Axcella Health Inc 相关性

10 最正相关
SEED	0.947
DZSI	0.941
POTX	0.94
INO	0.937
VIVE	0.933
RKDA	0.927
CHB	0.926
KRKR	0.926
PRPO	0.925
AQB	0.925

10 最负相关
MPRA	-0.943
NCAC	-0.941
APXI	-0.936
VMGA	-0.93
SCRM	-0.927
ALSA	-0.927
ZING	-0.926
TRON	-0.926
ARTEU	-0.924
ADAL	-0.921

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Axcella Health Inc 相关性 - 货币/商品

-0.64
( weak negative )

-0.47
( neutral )

0.53
( weak )

-0.30
( neutral )

0.43
( neutral )

Axcella Health Inc 财务报表

Annual	2022
营收:	$0
毛利润:	$0 (0.00 %)
EPS:	$-1.520

FY	2022
营收:	$0
毛利润:	$0 (0.00 %)
EPS:	$-1.520

FY	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-1.700

FY	2020
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-1.780

Financial Reports:

No articles found.

Axcella Health Inc

Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence; and AXA1125 that is in Phase 2b clinical trial for treating non-alcoholic steatohepatitis, as well as in Phase 2a clinical trial for Long COVID therapy for patients. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.

实时更新： Axcella Health Inc [AXLA]

Upcoming Earnings Alert